Masahiro Tanaka

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Trends in pertussis among infants in the United States, 1980-1999
    Masahiro Tanaka
    Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 290:2968-75. 2003
  2. ncbi request reprint Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Cancer Sci 98:605-11. 2007

Collaborators

  • F Brian Pascual
  • Hiroaki Yanagimoto
  • Shigenori Honma
  • Yasuo Kamiyama
  • Kanji Takahashi
  • Kimika Nakahara
  • Soichiro Takai
  • Naoyoshi Terakawa
  • Takashi Mine
  • Akira Yamada
  • Masaaki Oka
  • Junko Mizoguchi
  • Kyogo Itoh
  • Koutaro Yamamoto
  • Sohei Satoi

Detail Information

Publications2

  1. ncbi request reprint Trends in pertussis among infants in the United States, 1980-1999
    Masahiro Tanaka
    Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 290:2968-75. 2003
    ..However, severe pertussis morbidity and mortality occur primarily among infants...
  2. ncbi request reprint Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Cancer Sci 98:605-11. 2007
    ..GEM did not inhibit the immune responses induced by personalized peptide vaccinations, and this new type of immunochemotherapy combination is recommended for further clinical study in APC patients...